Naunyn-Schmiedeberg's Archives of Pharmacology

Erschienen in:

01.03.2018 | Original Article

Betulinic acid alleviates dextran sulfate sodium-induced colitis and visceral pain in mice

verfasst von: Jaspreet Kalra, Madhu Cholenahalli Lingaraju, Karikalan Mathesh, Dhirendra Kumar, Subhashree Parida, Thakur Uttam Singh, Anil Kumar Sharma, Dinesh Kumar, Surendra Kumar Tandan

Erschienen in: Naunyn-Schmiedeberg's Archives of Pharmacology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Betulinic acid (BA) exhibits many biological effects including anti-inflammatory and anti-oxidant activities. Free radicals and pro-inflammatory mediators play an important role in the pathology of inflammatory bowel disease (IBD) and associated pain. We, therefore, examined the anti-oxidant, anti-inflammatory, and anti-nociceptive potential of BA in colitis. Colitis was induced with 3% (w/v) dextran sulfate sodium (DSS) in drinking water in mice for 1to7 days. BA (3, 10 and 30 mg/kg) was given orally for 0 to 7 days. BA was also tested for its efficacy in acetic acid and mustard oil-induced visceral nociception in mice at same doses. BA significantly prevented diarrhea; bleeding and colonic pathological changes induced by DSS. Further, BA reduced the colon nitrite, malondialdehyde, myeloperoxidase, and lipid hydroperoxide levels and restored the superoxide dismutase, catalase and reduced glutathione levels to normalize the redox balance in DSS-exposed mice. Inflammatory mediators like matrix metalloproteinase-9 and prostaglandin E2 levels were also significantly attenuated by BA in colitis mice. Additionally, BA reduced acetic acid and mustard oil-induced visceral pain in mice. In conclusion, the results of the present study suggest that BA possesses good anti-nociceptive activity and the anti-IBD effects of BA are due to its anti-oxidant and anti-inflammatory potential.

Alzoghaibi MA (2013) Concepts of oxidative stress and antioxidant defense in Crohn’s disease. World J Gastroenterol 19(39):6540–6547. https://doi.org/10.3748/wjg.v19.i39.6540 CrossRefPubMedPubMedCentral

Amrouche-Mekkioui I, Djerdjouri B (2012) N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice. Eur J Pharmacol 691(1-3):209–217. https://doi.org/10.1016/j.ejphar.2012.06.014 CrossRefPubMed

Beyak MJ, Vanner S (2005) Inflammation induced hyperexcitability of nociceptive gastrointestinal DRG neurones: the role of voltage gated ion channels. Neurogastroenterol Motil 17(2):175–186. https://doi.org/10.1111/j.1365-2982.2004.00596.x CrossRefPubMed

Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE (2014) Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev 94(2):329–354. https://doi.org/10.1152/physrev.00040.2012 CrossRefPubMedPubMedCentral

Boismenu R, Chen Y (2000) Insights from mouse models of colitis. J Leukoc Biol 67(3):267–278CrossRefPubMed

Brandhorst G, Weigand S, Eberle C, Raddatz D, Karaus M, Oellerich M, Walson PD (2013) CD41 immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity. Clin Chim Acta 421:31–33. https://doi.org/10.1016/j.cca.2013.02.016 CrossRefPubMed

Buanne P, Di Carlo E, Caputi L, Brandolini L, Mosca M, Cattani F, Pellegrini L, Biordi L, Coletti G, Sorrentino C, Fedele G, Colotta F, Melillo G, Bertini R (2007) Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. J Leukoc Biol 82(5):1239–1246. https://doi.org/10.1189/jlb.0207118 CrossRefPubMed

Casagrande R, Georgetti SR, Verri WA Jr, Dorta DJ, dos Santos AC, Fonseca MJ (2006) Protective effect of topical formulations containing quercetin against UVB-induced oxidative stress in hairless mice. J Photochem Photobiol B 84(1):21–27. https://doi.org/10.1016/j.jphotobiol.2006.01.006 CrossRefPubMed

Cooper HS, Murthy SN, Shah RS, Sedergran DJ (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Investig 69(2):238–249PubMed

Cross RK, Wilson KT (2003) Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis 9(3):179–189. https://doi.org/10.1097/00054725-200305000-00006 CrossRefPubMed

Debnath T, Kim d H, Lim BO (2013) Natural products as a source of anti- inflammatory agents associated with inflammatory bowel disease. Molecules 18(6):7253–7270. https://doi.org/10.3390/molecules18067253 CrossRefPubMed

Gaudio E, Taddei G, Vetuschi A, Sferra R, Frieri G, Ricciardi G, Caprilli R (1999) Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig Dis Sci 44(7):1458–1475. https://doi.org/10.1023/A:1026620322859 CrossRefPubMed

Geboes K, Riddell R, Öst Ä, Jensfelt B, Persson T, Löfberg R (2000) A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47(3):404–409. https://doi.org/10.1136/gut.47.3.404 CrossRefPubMedPubMedCentral

Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem 126(1):131–138. https://doi.org/10.1016/0003-2697(82)90118-X CrossRefPubMed

Halliwell B, Gutteridge JM (1990) The antioxidants of human extracellular fluids. Arch Biochem Biophys 280(1):1–8. https://doi.org/10.1016/0003-9861(90)90510-6 CrossRefPubMed

Hokari R, Kato S, Matsuzaki K, Kuroki M, Iwai A, Kawaguchi A, Nagao S, Miyahara T, Itoh K, Sekizuka E, Nagata H, Ishii H, Miura S (2001) Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic Biol Med 31(2):153–163. https://doi.org/10.1016/S0891-5849(01)00565-2 CrossRefPubMed

Jahanshahi G, Motavasel V, Rezaie A, Hashtroudi AA, Daryani NE, Abdollahi M (2004) Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig Dis Sci 49(11-12):1752–1757. https://doi.org/10.1007/s10620-004-9564-5 CrossRefPubMed

Jalil J, Sabandar CW, Ahmat N (2015) Inhibitory effect of triterpenoids from Dillenia serrata (Dilleniaceae) on prostaglandin E2 production and quantitative HPLC analysis of its koetjapic acid and betulinic acid contents. Molecules 20(2):3206–3220. https://doi.org/10.3390/molecules20023206 CrossRefPubMed

Koike K, Moore FA, Moore EE (1992) Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. J Surg Res 52(6):656–662. https://doi.org/10.1016/0022-4804(92)90145-P CrossRefPubMed

Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186(1):189–195. https://doi.org/10.1016/0003-9861(78)90479-4 CrossRefPubMed

Laird JM, Martinez-Caro L, Garcia-Nicas E, Cervero F (2001) A new model of visceral pain and referred hyperalgesia in the mouse. Pain 92(3):335–342. https://doi.org/10.1016/S0304-3959(01)00275-5 CrossRefPubMed

Lee IA, Park YJ, Yeo HK, Han MJ, Kim DH (2010) Soyasaponin I attenuates TNBS-induced colitis in mice by inhibiting NF-κB pathway. J Agric Food Chem 58(20):10929–10934. https://doi.org/10.1021/jf102296y CrossRefPubMed

Lingaraju MC, Pathak NN, Begum J, Balaganur V, Bhat RA, Ramachandra HD, Ayanur A, Ram M, Singh V, Kumar D, Kumar D, Tandan SK (2015a) Betulinic acid attenuates lung injury by modulation of inflammatory cytokine response in experimentally-induced polymicrobial sepsis in mice. Cytokine 71(1):101–108. https://doi.org/10.1016/j.cyto.2014.09.004 CrossRefPubMed

Lingaraju MC, Pathak NN, Begum J et al (2015b) Betulinic acid negates oxidative lung injury in surgical sepsis model. J Surg Res 193:856–867CrossRefPubMed

Lingaraju MC, Pathak NN, Begum J, Balaganur V, Ramachandra HD, Bhat RA, Ram M, Singh V, Kandasamy K, Kumar D, Kumar D, Tandan SK (2015c) Betulinic acid attenuates renal oxidative stress and inflammation in experimental model of murine polymicrobial sepsis. Eur J Pharm Sci 70:12–21. https://doi.org/10.1016/j.ejps.2015.01.001 CrossRefPubMed

Liu H, Patel NR, Walter L, Ingersoll S, Sitaraman SV, Garg P (2013) Constitutive expression of MMP9 in intestinal epithelium worsens murine acute colitis and is associated with increased levels of proinflammatory cytokine Kc. Am J Physiol Gastrointest Liver Physiol 304(9):G793–G803. https://doi.org/10.1152/ajpgi.00249.2012 CrossRefPubMed

Luck H (1965) In: methods of enzymatic analysis, 2nd edn. Academic Press, New York, pp 885–890CrossRef

Marchioni BR, Kane S (2014) Current approaches to the management of new-onset ulcerative colitis. Clin Exp Gastroenterol 7:111–132

Matos I, Bento AF, Marcon R, Claudino RF, Calixto JB (2013) Preventive and therapeutic oral administration of the pentacyclic triterpene α, β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system. Mol Immunol 54(3-4):482–492. https://doi.org/10.1016/j.molimm.2013.01.018 CrossRefPubMed

McCartney SA, Mitchell JA, Fairclough PD, Farthing MJ, Warner TD (1999) Selective COX-2 inhibitors and human inflammatory bowel disease. Aliment Pharmacol Ther 13(8):1115–1117. https://doi.org/10.1046/j.1365-2036.1999.00585.x CrossRefPubMed

Mohammad FK, Al-Baggou BKH, Naser AS (2012) Antinociception by metoclopramide, ketamine and their combinations in mice. Pharmacol Rep 64(2):299–304. https://doi.org/10.1016/S1734-1140(12)70768-5 CrossRefPubMed

Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP (1994) Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 220(2):403–409. https://doi.org/10.1006/abio.1994.1357 CrossRefPubMed

Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98(3):694–702. https://doi.org/10.1016/0016-5085(90)90290-H CrossRefPubMed

Oliveira LGD, Cunha ALD, Duarte ALDAC, Castañon MC, Chebli JM, Aguiar JA (2014) Positive correlation between disease activity index and matrix metalloproteinases activity in a rat model of colitis. Arq Gastroenterol 51(2):107–112. https://doi.org/10.1590/S0004-28032014000200007 CrossRefPubMed

Oyebanji BO, Saba AB, Oridupa OA (2013) Studies on the anti-inflammatory, analgesic and antipyrexic activities of betulinic acid derived from Tetracera potatoria. Afr J Tradit Complement Altern Med 11:30–33PubMedPubMedCentral

Piechota-Polanczyk A, Fichna J (2014) The role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases. Naunyn Schmiedeberg’s Arch Pharmacol 387(7):605–620. https://doi.org/10.1007/s00210-014-0985-1 CrossRef

Quan HY, Kim DY, Kim SJ, Jo HK, Kim GW, Chung SH (2013) Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway. Biochem Pharmacol 85(9):1330–1340. https://doi.org/10.1016/j.bcp.2013.02.007 CrossRefPubMed

Rehman S, Chandra O, Abdulla M (1995) Evaluation of malondialdehyde as an index of lead damage in rat brain homogenates. Biometals 8:275–279PubMed

Roberts PJ, Morgan K, Miller R, Hunter JO, Middleton SJ (2001) Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut 48(4):468–472. https://doi.org/10.1136/gut.48.4.468 CrossRefPubMedPubMedCentral

Rzeski W, Stepulak A, Szymański M, Sifringer M, Kaczor J, Wejksza K, Zdzisińska B, Kandefer-Szerszeń M (2006) Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells. Naunyn Schmiedberg’s Arch Pharmacol 374(1):11–20. https://doi.org/10.1007/s00210-006-0090-1 CrossRef

Sakanaka T, Inoue T, Yorifuji N, Iguchi M, Fujiwara K, Narabayashi K, Kakimoto K, Nouda S, Okada T, Kuramoto T, Ishida K, Abe Y, Takeuchi T, Umegaki E, Akiba Y, Kaunitz JD, Higuchi K (2015) The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice. J Gastroenterol Hepatol 30:60–65. https://doi.org/10.1111/jgh.12740 CrossRefPubMedPubMedCentral

Sánchez-Fidalgo S, Cárdeno A, Sánchez-Hidalgo M, Aparicio-Soto M, de la Lastra CA (2013) Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice. J Nutr Biochem 24(7):1401–1413. https://doi.org/10.1016/j.jnutbio.2012.11.008 CrossRefPubMed

Sandborn WJ (2012) The future of inflammatory bowel disease therapy: where do we go from here? Dig Dis 30(s3):140–144. https://doi.org/10.1159/000342742 CrossRefPubMed

Santana A, Medina C, Paz-Cabrera MC, Díaz-Gonzalez F, Farré E, Salas A, Radomski MW, Quintero E (2006) Attenuation of dextran sodium sulphate induced colitis in matrix metallopro-teinase-9 deficient mice. World J Gastroenterol 12(40):6464–6472. https://doi.org/10.3748/wjg.v12.i40.6464 CrossRefPubMedPubMedCentral

Saria A, Lundberg JM (1983) Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods 8(1):41–49. https://doi.org/10.1016/0165-0270(83)90050-X CrossRefPubMed

Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25(1):192–205. https://doi.org/10.1016/0003-2697(68)90092-4 CrossRefPubMed

Şener TE, Kardaş RC, Şehirli AO et al (2013) The effect of betulinic acid on TNBS-induced experimental colitis. Marmara. Pharm J 17:52–59

Sharma A, Thakur R, Lingaraju MC, Kumar D, Mathesh K, Telang AG, Singh TU, Kumar D (2017) Betulinic acid attenuates renal fibrosis in rat chronic kidney disease model. Biomed Pharmacother 89:796–804. https://doi.org/10.1016/j.biopha.2017.01.181 CrossRefPubMed

Shiba Y, Kinoshita T, Chuman H, Taketani Y, Takeda E, Kato Y, Naito M, Kawabata K, Ishisaka A, Terao J, Kawai Y (2008) Flavonoids as substrates and inhibitors of myeloperoxidase: molecular actions of aglycone and metabolites. Chem Res Toxicol 21(8):1600–1609. https://doi.org/10.1021/tx8000835 CrossRefPubMed

Sipos F, Muzes G, Galamb O, Spisák S, Krenács T, Tóth K, Tulassay Z, Molnár B (2010) The possible role of isolated lymphoid follicles in colonic mucosal repair. Pathol Oncol Res 16(1):11–18. https://doi.org/10.1007/s12253-009-9181-x CrossRefPubMed

Viji V, Helen A, Luxmi VR (2011) Betulinic acid inhibits endotoxin-stimulated phosphorylation cascade and pro-inflammatory prostaglandin E2 production in human peripheral blood mononuclear cells. Br J Pharmacol 162(6):1291–1303. https://doi.org/10.1111/j.1476-5381.2010.01112.x CrossRefPubMedPubMedCentral

Wirtz S, Neurath MF (2007) Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 59(11):1073–1083. https://doi.org/10.1016/j.addr.2007.07.003 CrossRefPubMed

Yogeeswari P, Sriram D (2005) Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem 12(6):657–666. https://doi.org/10.2174/0929867053202214 CrossRefPubMed

Zhu H, Li YR (2012) Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Exp Biol Med (Maywood) 237(5):474–480. https://doi.org/10.1258/ebm.2011.011358 CrossRef

Zimmerman M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16(2):109–110. https://doi.org/10.1016/0304-3959(83)90201-4 CrossRef

Qu ZW, Liu TT, Ren C, Gan X, Qiu CY, Ren P, Rao Z, WP H (2015) 17β-estradiol enhances ASIC activity in primary sensory neurons to produce sex difference in acidosis-induced nociception. Endocrinology 156:4660–4671CrossRefPubMed

Titel: Betulinic acid alleviates dextran sulfate sodium-induced colitis and visceral pain in mice
verfasst von: Jaspreet Kalra
Madhu Cholenahalli Lingaraju
Karikalan Mathesh
Dhirendra Kumar
Subhashree Parida
Thakur Uttam Singh
Anil Kumar Sharma
Dinesh Kumar
Surendra Kumar Tandan
Publikationsdatum: 01.03.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Naunyn-Schmiedeberg's Archives of Pharmacology / Ausgabe 3/2018
Print ISSN: 0028-1298
Elektronische ISSN: 1432-1912
DOI: https://doi.org/10.1007/s00210-017-1455-3

Omega-3 fatty acids supplementation with lithium and aripiprazole for improving the balance of circulating hormones and brain neurotransmitters in manic mice model

Original Article

Apigenin reduces the Toll-like receptor-4-dependent activation of NF-κB by suppressing the Akt, mTOR, JNK, and p38-MAPK

Original Article

NK2 and NK1 receptor-mediated effects of NKA and analogs on colon, bladder, and arterial pressure in anesthetized dogs

Original Article

Correction to: Meeting report of the 8th International Conference on "cGMP BcGMP: generators, effectors, and therapeutic implications" at Bamberg, Germany, from June 23 to 25, 2017

Correction

DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure

Original Article

Effect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats

Brief Communication

Springer Medizin

Betulinic acid alleviates dextran sulfate sodium-induced colitis and visceral pain in mice

Abstract

Weitere Artikel der Ausgabe 3/2018

Omega-3 fatty acids supplementation with lithium and aripiprazole for improving the balance of circulating hormones and brain neurotransmitters in manic mice model

Apigenin reduces the Toll-like receptor-4-dependent activation of NF-κB by suppressing the Akt, mTOR, JNK, and p38-MAPK

NK2 and NK1 receptor-mediated effects of NKA and analogs on colon, bladder, and arterial pressure in anesthetized dogs

Correction to: Meeting report of the 8th International Conference on "cGMP BcGMP: generators, effectors, and therapeutic implications" at Bamberg, Germany, from June 23 to 25, 2017

DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure

Effect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Omega-3 fatty acids supplementation with lithium and aripiprazole for improving the balance of circulating hormones and brain neurotransmitters in manic mice model

Apigenin reduces the Toll-like receptor-4-dependent activation of NF-κB by suppressing the Akt, mTOR, JNK, and p38-MAPK

NK2 and NK1 receptor-mediated effects of NKA and analogs on colon, bladder, and arterial pressure in anesthetized dogs

Correction to: Meeting report of the 8th International Conference on "cGMP BcGMP: generators, effectors, and therapeutic implications" at Bamberg, Germany, from June 23 to 25, 2017

DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure

Effect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats